ClinicalTrials.gov
public full text
Public Domain
The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder
This study aims to investigate the effects of methylphenidate on symptomatology in individuals with borderline personality disorder. Specifically, it will evaluate whether Concerta is effective in reducing impulsivity, mood instability, and inattention among patients with BPD. Additionally, the study will assess Concerta's safety profile in this population to determine its potential as a supportive pharmacological option in BPD management.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Specialized Healthcare Service for BPD Patients: Athens Trial#859747
- Physical Activity in People With Borderline Personality Disorder (PABORD)#993296
- Impulsivity With Borderline Personality Disorder/tMS#1139620
- Intervención conductual y desempeño académico en estudiantes universitarios con Trastorno Límite de la Personalidad: Estudio de caso#1165321
- An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)#866271
Record · ID 896591
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive